Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow von Boiret, Nathalie, Rapatel, Chantal, Veyrat-Masson, Richard, Guillouard, Laurent, Guérin, Jean-Jacques, Pigeon, Pascale, Descamps, Stéphane, Boisgard, Stéphane, Berger, Marc Gabriel

Volltext

Double L611S/V617F JAK2 mutation in a child with erythrocytosis von Lebecque, Benjamin, Grèze, Victoria, Tassin, Thomas, Mareynat, Gabrielle, Dannus, Louis‐Thomas, Boiret‐Dupré, Nathalie, Veyrat‐Masson, Richard, Tribalat, Nathalie, Berger, Marc Gabriel, Bourgne, Céline

Volltext

Hematologic and Hemato-Oncologic Aspects of Gaucher Disease von Hughes, Derralynn, MA, DPhil, MRCP, MRCPath, Domenica Cappellini, Maria, MD, Berger, Marc Gabriel, MD, PhD, Van Droogenbroeck, Jan, MD, de Fost, Maaike, MD, Janic, Dragana, MD, PhD, Marinakis, Theodore, MD, PhD, Rosenbaum, Hanna, MD, Villarubia, Jesús, MD, PhD, Zhukovskaya, Elena, MD, Hollak, Carla, MD

Volltext

XE-2100: amas de plaquettes ou de leucocytes, telle est la question von DUBOIS-GALOPIN, Frédérique, LAMBALLAIS, Florence, RAPATEL, Chantal, BERGER, Marc Gabriel

Volltext

Cell Culture Medium Composition and Translational Adult Bone Marrow‐Derived Stem Cell Research von Berger, Marc Gabriel, Veyrat‐Masson, Richard, Rapatel, Chantal, Descamps, Stéphane, Chassagne, Jacques, Boiret‐Dupre, Nathalie

Volltext

XE-2100: platelet clumps or polymorphonuclear neutrophil aggregates, that is the question von Dubois-Galopin, Frédérique, Lamballais, Florence, Rapatel, Chantal, Berger, Marc Gabriel

Volltext

CD34 +CDw90(Thy-1) + subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and long-term culture... von Boiret, Nathalie, Rapatel, Chantal, Boisgard, Stéphane, Charrier, Sabine, Tchirkov, Andréi, Bresson, Caroline, Camilleri, Lionel, Berger, Juliette, Guillouard, Laurent, Guérin, Jean-Jacques, Pigeon, Pascale, Chassagne, Jacques, Berger, Marc Gabriel

Volltext

Normal human bone marrow CD34 +CD133 + cells contain primitive cells able to produce different categories of colony-forming unit megakaryocytes in vitro von Charrier, Sabine, Boiret, Nathalie, Fouassier, Marc, Berger, Juliette, Rapatel, Chantal, Pigeon, Pascale, Mareynat, Gabrielle, Bonhomme, Jean, Camilleri, Lionel, Berger, Marc Gabriel

Volltext

Double L611S/V617F JAK2 mutation in a child with erythrocytosis von Lebecque, Benjamin, Grèze, Victoria, Tassin, Thomas, Mareynat, Gabrielle, Dannus, Louis-Thomas, Boiret-Dupré, Nathalie, Veyrat-Masson, Richard, Tribalat, Nathalie, Berger, Marc Gabriel, Bourgne, Céline

Volltext

Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells von Berger, Marc G., Lebecque, Benjamin, Tassin, Thomas, Dannus, Louis-Thomas, Berger, Juliette, Soucal, Mélanie, Guerci, Agnès, Cony-Makhoul, Pascale, Johnson, Hyacinthe, Etienne, Gabriel, Guyotat, Denis, Gagnieu, Marie-Claude, Pereira, Bruno, Saugues, Sandrine, Tournilhac, Olivier, Hermet, Eric, Bourgne, Céline

Volltext

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial von Saussele, Susanne, Richter, Johan, Guilhot, Joelle, Gruber, Franz X, Hjorth-Hansen, Henrik, Almeida, Antonio, Janssen, Jeroen J W M, Mayer, Jiri, Koskenvesa, Perttu, Panayiotidis, Panayiotis, Olsson-Strömberg, Ulla, Martinez-Lopez, Joaquin, Rousselot, Philippe, Vestergaard, Hanne, Ehrencrona, Hans, Kairisto, Veli, Machová Poláková, Katerina, Müller, Martin C, Mustjoki, Satu, Berger, Marc G, Fabarius, Alice, Hofmann, Wolf-Karsten, Hochhaus, Andreas, Pfirrmann, Markus, Mahon, Francois-Xavier, Ossenkoppele, Gert, Pagoni, Maria N., Söderlund, Stina, Escoffre-Barbe, Martine, Etienne, Gabriel, Dengler, Jolanta, Huguet, Francoise, von Bubnoff, Nikolas, Klamova, Hana, Faber, Edgar, Guilhot, Francois, Lotfi, Kourosh, Rea, Delphine, Brümmendorf, Tim H., de Greef, Gorgine E., Stenke, Leif, Nicolini, Franck E., Legros, Laurence, Burchert, Andreas, Voglova, Jaroslava, Charbonnier, Aude, Gyan, Emmanuel, Kunzmann, Volker, Westerweel, Peter E.

Volltext

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients von Nicolini, Franck Emmanuel, Dulucq, Stéphanie, Boureau, Lisa, Cony-Makhoul, Pascale, Charbonnier, Aude, Escoffre-Barbe, Martine, Rigal-Huguet, Françoise, Coiteux, Valérie, Varet, Bruno, Dubruille, Viviane, Lenain, Pascal, Rousselot, Philippe, Rea, Delphine, Guerci-Bresler, Agnès, Legros, Laurence, Liu, Jixing, Gardembas, Martine, Ianotto, Jean-Christophe, Turlure, Pascal, Johnson-Ansah, Hyacinthe, Martiniuc, Juliana, Jardel, Henry, Joly, Bertrand, Zunic, Patricia, Henni, Tawfiq, Villemagne, Bruno, Berger, Marc G, Cayssials, Emilie, Guilhot, François, Larosa, Fabrice, Guilhot, Joëlle, Etienne, Gabriel, Mahon, François-Xavier

Volltext

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group von Rea, Delphine, Ame, Shanti, Berger, Marc, Cayuela, Jean‐Michel, Charbonnier, Aude, Coiteux, Valérie, Cony‐Makhoul, Pascale, Dubruille, Viviane, Dulucq, Stéphanie, Etienne, Gabriel, Legros, Laurence, Nicolini, Franck, Roche‐Lestienne, Catherine, Escoffre‐Barbe, Martine, Gardembas, Martine, Guerci‐Bresler, Agnès, Johnson‐Ansah, Hyacinthe, Rigal‐Huguet, Françoise, Rousselot, Philippe, Mahon, François‐Xavier

Volltext

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15− cells in early chronic‐phase chronic myeloid leukemia von Maupetit‐Mehouas, Stéphanie, Court, Franck, Bourgne, Céline, Guerci‐Bresler, Agnès, Cony‐Makhoul, Pascale, Johnson, Hyacinthe, Etienne, Gabriel, Rousselot, Philippe, Guyotat, Denis, Janel, Alexandre, Hermet, Eric, Saugues, Sandrine, Berger, Juliette, Arnaud, Philippe, Berger, Marc G.

Volltext

Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial von Efficace, Fabio, Mahon, Francois-Xavier, Richter, Johan, Piciocchi, Alfonso, Cipriani, Marta, Nicolini, Franck E., Mayer, Jiri, Zackova, Daniela, Janssen, Jeroen J. W. M., Panayiotidis, Panayiotis, Vestergaard, Hanne, Koskenvesa, Perttu, Almeida, Antonio, Hjorth-Hansen, Henrik, Martinez-Lopez, Joaquin, Olsson-Strömberg, Ulla, Hochhaus, Andreas, Berger, Marc G., Etienne, Gabriel, Klamova, Hana, Faber, Edgar, Rousselot, Philippe, Pfirrmann, Markus, Saussele, Susanne

Volltext

Sleeve Gastrectomy Severe Complications: Is It Always a Reasonable Surgical Option? von Moszkowicz, David, Arienzo, Roberto, Khettab, Idir, Rahmi, Gabriel, Zinzindohoué, Franck, Berger, Anne, Chevallier, Jean-Marc

Volltext

Long-Term Evaluation of Biliary Reflux on Esogastric Mucosae after One-Anastomosis Gastric Bypass and Esojejunostomy in Rats von M’Harzi, Leïla, Chevallier, Jean-Marc, Certain, Anais, Autret, Gwennhaël, Levenson, Guillaume, Louis, David, Poghosyan, Tigran, Berger, Arthur, Rahmi, Gabriel, Broudin, Chloé, Clément, Olivier, Douard, Richard, Tavitian, Bertrand, Bruzzi, Matthieu

Volltext

Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome: The SOLID-TIMI 52 Randomized Clinical Trial von O’Donoghue, Michelle L, Braunwald, Eugene, White, Harvey D, Steen, Dylan P, Lukas, Mary Ann, Tarka, Elizabeth, Steg, P. Gabriel, Hochman, Judith S, Bode, Christoph, Maggioni, Aldo P, Im, KyungAh, Shannon, Jennifer B, Davies, Richard Y, Murphy, Sabina A, Crugnale, Sharon E, Wiviott, Stephen D, Bonaca, Marc P, Watson, David F, Weaver, W. Douglas, Serruys, Patrick W, Cannon, Christopher P

Volltext

Last Interim Results of the Real-Life Study Evaluating the Efficacy and Safety of Ponatinib "Topase” in Patients with TKI-Resistant or Intolerant CML von Cayssials, Emilie, Etienne, Gabriel, Turhan, Ali G, Rousselot, Philippe, Coiteux, Valerie, Berger, Marc G., Huguet, Francoise, Guerci-Bresler, Agnes

Volltext

Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial von Dulucq, Stéphanie, Nicolini, Franck E, Rea, Delphine, Cony-Makhoul, Pascale, Charbonnier, Aude, Escoffre-Barbe, Martine, Coiteux, Valérie, Lenain, Pascal, Rigal-Huguet, Françoise, Liu, Jixing, Guerci-Bresler, Agnès, Legros, Laurence, Ianotto, Jean-Christophe, Gardembas, Martine, Turlure, Pascal, Dubruille, Viviane, Rousselot, Philippe, Martiniuc, Juliana, Jardel, Henry, Johnson-Ansah, Hyacinthe, Joly, Bertrand, Henni, Tawfiq, Cayssials, Emilie, Zunic, Patricia, Berger, Marc G, Villemagne, Bruno, Robbesyn, Fanny, Morisset, Stephane, Mahon, François-Xavier, Etienne, Gabriel

Volltext